Status:
COMPLETED
Change in Symptom Clusters in HNC Patients
Lead Sponsor:
Taipei Medical University
Conditions:
Neoplasms, Head and Neck
Eligibility:
All Genders
Brief Summary
Head and neck cancer (HNC) is the sixth most common malignancy worldwide, causing more than 379,000 deaths in 2015 notwithstanding the breakthrough in cancer screening and medical treatment. The prima...
Eligibility Criteria
Inclusion
- Newly diagnosed with HNC,
- Aged older than 18 years,
- Without receiving any radiotherapy prior to surgery,
- No cognitive impairment and able to communicate in Mandarin or Taiwanese
Exclusion
- \- Undergoing any concurrent treatment for cancer.
Key Trial Info
Start Date :
January 1 2015
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
January 1 2017
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT03356093
Start Date
January 1 2015
End Date
January 1 2017
Last Update
November 29 2017
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.